Diffuse large B cell lymphoma is a type of non Hodgkin lymphoma that develops from abnormal B lymphocytes. Accurate diagnosis is important because several lymphoma types can have similar symptoms but may differ in their biological features and clinical characteristics. The diagnostic process can include a medical history review, physical examination, tissue biopsy, laboratory tests, imaging studies, and specialized pathology testing. These assessments help healthcare professionals identify the lymphoma type and evaluate how extensively it may be present in the body. Understanding the general diagnostic process can help patients and families become more familiar with the tests and information involved.
Diffuse large B cell lymphoma, commonly called DLBCL, is one of the more common forms of non Hodgkin lymphoma. It affects B lymphocytes, which are white blood cells involved in immune system function. Symptoms and test results alone are generally not enough to confirm DLBCL, so healthcare professionals use several diagnostic methods to examine tissue, identify cellular characteristics, and understand the extent of the disease.
The diagnostic process often begins with a review of symptoms and medical history. A healthcare professional may ask about enlarged lymph nodes, unexplained fever, night sweats, fatigue, or unintentional weight changes. A physical examination may also include checking the neck, underarm, and groin areas for enlarged lymph nodes and assessing other areas of the body when appropriate.
A tissue biopsy is generally an important part of confirming lymphoma. During this procedure, a sample from an enlarged lymph node or another affected area is collected for examination. A pathologist studies the cells under a microscope and may use additional laboratory methods to identify whether the abnormal cells have features associated with DLBCL.
Common parts of the diagnostic evaluation may include:
The results of these tests are considered together because lymphoma diagnosis involves identifying the specific type and characteristics of the abnormal cells.
After DLBCL is identified, additional tests may be used to determine where lymphoma is present. This process is known as staging. Imaging studies can help healthcare professionals evaluate lymph nodes and organs throughout the body and understand the distribution of the disease.
PET scans and CT scans are commonly used imaging methods during the evaluation of lymphoma. In some situations, additional procedures may be considered depending on individual findings and medical circumstances. Healthcare professionals may also review laboratory results to obtain a broader picture of a person's health before discussing the next stages of care.
Tests and assessments that may contribute to staging include:
An accurate DLBCL diagnosis depends on careful examination of tissue and supporting test results. Because different forms of lymphoma can have overlapping symptoms and appearances, specialized pathology and staging assessments can provide important information about the specific disease characteristics. The diagnostic process may vary between individuals based on symptoms, biopsy findings, and other clinical factors. This information is intended for educational purposes only and does not replace guidance from qualified healthcare professionals.